Corrigendum: Notoginsenoside R1 Reverses Abnormal Autophagy in Hippocampal Neurons of Mice With Sleep Deprivation Through Melatonin Receptor 1A

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

In the original article, there was an error in the Funding statement. The correct number for the funder “Youth Project of Anhui Natural Science Foundation” is 2108085QH372, not 2108085QH3720. There was also a mistake in Figure 7, the chemical form of NGR1 is incorrect. The correct Figure 7 appears below. FIGURE 7 Notoginsenoside R1 reverses abnormal autophagy in hippocampal neuron of mice with sleep deprivation through melatonin receptor 1A. The authors apologize for these errors and state that this do not change the scientific conclusions of the article in any way. The original article has been updated.

Related collections

Author and article information

Contributors

Yin Cao: URI : https://loop.frontiersin.org/people/1300785/overview

Qinglin Li: URI : https://loop.frontiersin.org/people/1462797/overview

Zunji Ke: URI : https://loop.frontiersin.org/people/502247/overview

Shengqi Chen: URI : https://loop.frontiersin.org/people/1318861/overview

Mingrui Li: URI : https://loop.frontiersin.org/people/1462251/overview

Zipeng Gong: URI : https://loop.frontiersin.org/people/1113110/overview

Zhengtao Wang: URI : https://loop.frontiersin.org/people/155555/overview

Xiaojun Wu: URI : https://loop.frontiersin.org/people/188899/overview

Journal

Journal ID (nlm-ta): Front Pharmacol

Journal ID (iso-abbrev): Front Pharmacol

Journal ID (publisher-id): Front. Pharmacol.

Title: Frontiers in Pharmacology

Publisher: Frontiers Media S.A.

ISSN (Electronic): 1663-9812

Publication date (Electronic): 19 January 2022

Publication date Collection: 2021

Publication date PMC-release: 19 January 2022

Volume: 12

Electronic Location Identifier: 832126

Affiliations

[1] ¹ Key Laboratory of Xin’an Medicine , Ministry of Education , Anhui Province Key Laboratory of R&D of Chinese Medicine , Anhui University of Chinese Medicine , Hefei, China

[2] ² Shanghai Key Laboratory of Compound Chinese Medicines , Institute of Chinese Materia Medica , Shanghai University of Traditional Chinese Medicine , Shanghai, China

[3] ³ State Key Laboratory of Functions and Applications of Medicinal Plants , Guizhou Provincial Key Laboratory of Pharmaceutics , Guizhou Medical University , Guiyang, China

[4] ⁴ Academy of Integrative Medicine , Shanghai University of Traditional Chinese Medicine , Shanghai, China

Author notes

Edited and reviewed by: Elisa Roda, Scientific Clinical Institute Maugeri (ICS Maugeri), Italy

*Correspondence: Zipeng Gong, gzp4012607@ 123456126.com ; Zhengtao Wang, ztwang@ 123456shutcm.edu.cn ; Xiaojun Wu, xiaojunwu320@ 123456126.com

This article was submitted to Neuropharmacology, a section of the journal Frontiers in Pharmacology

Article

Publisher ID: 832126

DOI: 10.3389/fphar.2021.832126

PMC ID: 8807644

PubMed ID: 35126155

SO-VID: 94e64402-b807-488c-b755-8ef72963e04e

License:

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

History

Date received : 09 December 2021

Date accepted : 30 December 2021

Comments

Comment on this article

scite_

Cited by 2

See all cited by

- Version 1